Peribronchiolitis and alveolitis scores were significantly decreased in CR treated with either Box A variant, whereas interstitial pneumonia was significantly reduced only in CR that had been treated with AdV.C3-Tat/HIV-Box AGly. Here, TAT is linked to hypersensitivity pneumonitis.